Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #5011
Reference
Drug alert
Name
Immediate: suspension of licences for hydroxyethyl starch intravenous infusion
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Advises that licences for all hydroxyethyl starch (HES) products have been suspended.following results from large randomised clinical trials.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Pharmacy and Medicines Division, Finance, e-Health and Pharmaceuticals Directorate, St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2013-06-27 00:00:00
Click to go back to homepage